There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:C12Q1/6886
Jump to navigation
Jump to search
Pages in category "C12Q1/6886"
The following 16 pages are in this category, out of 16 total.
1
- 18264314. METHODS AND BIOMARKERS IN CANCER simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18363584. MARKERS OF ACUTE MYELOID LEUKEMIA STEM CELLS simplified abstract (THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY)
- 18457634. CANCER EXAMINATION REAGENT SET, PRODUCTION METHOD FOR CANCER EXAMINATION REAGENT SET, AND CANCER EXAMINATION METHOD simplified abstract (FUJIFILM Corporation)
- 18461820. MEK1 Mutation Conferring Resistance to RAF and MEK Inhibitors simplified abstract (DANA-FARBER CANCER INSTITUTE, INC.)
- 18464360. C-RAF Mutants that Confer Resistance to RAF Inhibitors simplified abstract (DANA-FARBER CANCER INSTITUTE, INC.)
2
- 20240026462. HOMOLOGOUS RECOMBINATION DEFICIENCY DETERMINING METHOD AND KIT THEREOF simplified abstract (ACT GENOMICS (IP) LIMITED)
- 20240043938. BIOMARKER PANEL AND METHODS FOR DETECTING MICROSATELLITE INSTABILITY IN CANCERS simplified abstract (Biocartis NV)
- 20240052423. METHODS OF IDENTIFYING A TUMOR THAT IS SENSITIVE TO TREATMENT WITH TALAZOPARIB AND METHODS OF TREATMENT THEREOF simplified abstract (Pfizer Inc.)
B
- Blockchain patent applications on April 11th, 2024
- Blockchain patent applications on February 15th, 2024
- Blockchain patent applications on February 8th, 2024
- Blockchain patent applications on January 25th, 2024
- Blockchain patent applications on March 14th, 2024
- Blockchain patent applications on March 28th, 2024